Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

Cardiogenic shock is a hemodynamically complex syndrome characterized by a low cardiac
output that often culminates in multiorgan system failure and death. Despite recent …

Objectives The purpose of this study was to investigate the association between obtaining
hemodynamic data from early pulmonary artery catheter (PAC) placement and outcomes in …

The use of temporary mechanical circulatory support in cardiogenic shock has increased
dramatically despite a lack of randomized controlled trials or evidence guiding clinical …

Background Single-center studies suggest that implementation of multidisciplinary
cardiogenic shock (CS) teams is associated with improved CS survival. Objectives The aim …

Cardiogenic shock (CS) remains the most common cause of mortality in patients with acute
myocardial infarction. The SHOCK trial (Should We Emergently Revascularize Occluded …

Background There is a lack of contemporary data on cardiogenic shock (CS) in‐hospital
mortality trends. Methods and Results Patients with CS admitted January 1, 2004 to …

The novel coronavirus disease 2019, otherwise known as COVID-19, is a global pandemic
with primary respiratory manifestations in those who are symptomatic. It has spread to> 187 …

Despite increasing prevalence in critical care units, cardiogenic shock related to HF (HF-CS)
is incompletely understood and distinct from acute myocardial infarction related CS. This …

See page 49 for disclosure information. List of abbreviations: ACT, activated clotting time;
aPTT, activated partial thromboplastin time; ACHD, adult congenital heart disease; ADHF …